🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Evaluation of Quality Indicators in Patients Receiving Intensive Care and Their Influence on Outcome Indicators and Economic Indicators

Recruitingn/aAges 18 Years - anyAllCharite University, Berlin, Germany
NCT07501494 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The aim of the study is to identify and evaluate incentive mechanisms for the implementation of quality-relevant care processes. The objective is to correlate adherence to individual process-based quality indicators or their combination with outcome data. In addition, cost shares and case revenues are evaluated. Indices are also derived from routine data that may represent additional influencing factors (Charlson Comorbidity Index or secondary diagnoses that increase case severity based on ICD-10 coding and procedures based on the Surgery and procedure codes system).

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients with complete, electronically documented intensive care treatment data, including vital sign monitor data and laboratory data from the patient documentation system. * Complete, electronically documented treatment data for these patients from the hospital information system (01.01.2012- 31.12.2024). * Data from cost and revenue accounting from the hospital information system, §21 routine data records. * Age ≥ 18 years * Length of stay \> 24 hours * Intensive care units from the Department of Anesthesiology and Intensive Care Medicie (CCM/CVK) of Charité - University Medicine Berlin: 2012- 2024: M101I, MPACU, WAN-S14I,WAN-S8I, WAN-PACU, 9i, WAC21i und W1i (2020-2022). Since the introduction of electronic patient records, some of these intensive care units have had different names (e.g., MAN-101i, MAN-103i, W1i). Exclusion Criteria: -none
💊

What it tests

  • Not listed
📍

Where

1 site
Department of Anaesthesiolgy and Intensive Care Medicine (CCM/CVK), Charite- University Berlin
Berlin, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy